1
|
Paulus J, Sewald N. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment. J Pept Sci 2024; 30:e3561. [PMID: 38382900 DOI: 10.1002/psc.3561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 11/15/2023] [Accepted: 11/16/2023] [Indexed: 02/23/2024]
Abstract
Targeted cancer treatment should avoid side effects and damage to healthy cells commonly encountered during traditional chemotherapy. By combining small molecule or peptidic ligands as homing devices with cytotoxic drugs connected by a cleavable or non-cleavable linker in peptide-drug conjugates (PDCs) or small molecule-drug conjugates (SMDCs), cancer cells and tumours can be selectively targeted. The development of highly affine, selective peptides and small molecules in recent years has allowed PDCs and SMDCs to increasingly compete with antibody-drug conjugates (ADCs). Integrins represent an excellent target for conjugates because they are overexpressed by most cancer cells and because of the broad knowledge about native binding partners as well as the multitude of small-molecule and peptidic ligands that have been developed over the last 30 years. In particular, integrin αVβ3 has been addressed using a variety of different PDCs and SMDCs over the last two decades, following various strategies. This review summarises and describes integrin-addressing PDCs and SMDCs while highlighting points of great interest.
Collapse
Affiliation(s)
- Jannik Paulus
- Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany
| | - Norbert Sewald
- Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany
| |
Collapse
|
2
|
Goher SS, Abdrabo WS, Veerakanellore GB, Elgendy B. 2,5-Diketopiperazines (DKPs): Promising Scaffolds for Anticancer Agents. Curr Pharm Des 2024; 30:597-623. [PMID: 38343054 DOI: 10.2174/0113816128291798240201112916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 01/22/2024] [Indexed: 05/25/2024]
Abstract
2,5-Diketopiperazine (2,5-DKP) derivatives represent a family of secondary metabolites widely produced by bacteria, fungi, plants, animals, and marine organisms. Many natural products with DKP scaffolds exhibited various pharmacological activities such as antiviral, antifungal, antibacterial, and antitumor. 2,5-DKPs are recognized as privileged structures in medicinal chemistry, and compounds that incorporate the 2,5-DKP scaffold have been extensively investigated for their anticancer properties. This review is a thorough update on the anti-cancer activity of natural and synthesized 2,5-DKPs from 1997 to 2022. We have explored various aspects of 2,5-DKPs modifications and summarized their structure-activity relationships (SARs) to gain insight into their anticancer activities. We have also highlighted the novel approaches to enhance the specificity and pharmacokinetics of 2,5-DKP-based anticancer agents.
Collapse
Affiliation(s)
- Shaimaa S Goher
- Chemistry Department, Faculty of Science, Benha University, Benha 13518, Egypt
- Nanotechnology Research Centre (NTRC), The British University in Egypt (BUE), Suez Desert Road, El Sherouk City, Cairo 1183, Egypt
| | - Wessam S Abdrabo
- Chemistry Department, Faculty of Science, Benha University, Benha 13518, Egypt
| | - Giri Babu Veerakanellore
- Center for Clinical Pharmacology, Washington University School of Medicine and University of Health Sciences and Pharmacy, St. Louis, Missouri 63110, United States
- Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63110, United States
| | - Bahaa Elgendy
- Chemistry Department, Faculty of Science, Benha University, Benha 13518, Egypt
- Center for Clinical Pharmacology, Washington University School of Medicine and University of Health Sciences and Pharmacy, St. Louis, Missouri 63110, United States
- Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63110, United States
| |
Collapse
|
3
|
Di Giorgio E, Ferino A, Huang W, Simonetti S, Xodo L, De Marco R. Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells. Front Pharmacol 2023; 14:1237478. [PMID: 37711175 PMCID: PMC10497945 DOI: 10.3389/fphar.2023.1237478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Accepted: 08/07/2023] [Indexed: 09/16/2023] Open
Abstract
The refractoriness of tumor cells to apoptosis represents the main mechanism of resistance to chemotherapy. Smac/DIABLO mimetics proved to be effective in overcoming cancer-acquired resistance to apoptosis as a consequence of overexpression of the anti-apoptotic proteins XIAP, cIAP1, and cIAP2. In this work, we describe a dual-targeting peptide capable of selectively activating apoptosis in cancer cells. The complex consists of a fluorescent periodic mesoporous organosilica nanoparticle that carries the short sequences of Smac/DIABLO bound to the αvβ3-integrin ligand. The dual-targeting peptide @PMO shows significantly higher toxicity in αvβ3-positive HeLa cells with respect to αvβ3-negative Ht29 cells. @PMO exhibited synergistic effects in combination with oxaliplatin in a panel of αvβ3-positive cancer cells, while its toxicity is overcome by XIAP overexpression or integrin β3 silencing. The successful uptake of the molecule by αvβ3-positive cells makes @PMO promising for the re-sensitization to apoptosis of many cancer types.
Collapse
Affiliation(s)
| | | | - Weizhe Huang
- Department of Agricultural, Food, Environmental and Animal Sciences (Di4A), University of Udine, Udine, Italy
| | - Sigrid Simonetti
- Department of Agricultural, Food, Environmental and Animal Sciences (Di4A), University of Udine, Udine, Italy
| | - Luigi Xodo
- Department of Medicine, University of Udine, Udine, Italy
| | - Rossella De Marco
- Department of Agricultural, Food, Environmental and Animal Sciences (Di4A), University of Udine, Udine, Italy
| |
Collapse
|
4
|
Yamaguchi K, Miyaguchi H, Hirakawa K, Ohno Y, Kanawaku Y. Qualitative analysis of zolpidem and its metabolites M-1 to M-4 in human blood and urine using liquid chromatography–tandem mass spectrometry. Forensic Toxicol 2020. [DOI: 10.1007/s11419-020-00551-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
De Marco R, Rampazzo E, Zhao J, Prodi L, Paolillo M, Picchetti P, Gallo F, Calonghi N, Gentilucci L. Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein. NANOMATERIALS (BASEL, SWITZERLAND) 2020; 10:E1211. [PMID: 32575872 PMCID: PMC7353088 DOI: 10.3390/nano10061211] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Revised: 06/14/2020] [Accepted: 06/18/2020] [Indexed: 01/08/2023]
Abstract
Cancer cells demonstrate elevated expression levels of the inhibitor of apoptosis proteins (IAPs), contributing to tumor cell survival, disease progression, chemo-resistance, and poor prognosis. Smac/DIABLO is a mitochondrial protein that promotes apoptosis by neutralizing members of the IAP family. Herein, we describe the preparation and in vitro validation of a synthetic mimic of Smac/DIABLO, based on fluorescent polyethylene glycol (PEG)-coated silica-core nanoparticles (NPs) carrying a Smac/DIABLO-derived pro-apoptotic peptide and a tumor-homing integrin peptide ligand. At low μM concentration, the NPs showed significant toxicity towards A549, U373, and HeLa cancer cells and modest toxicity towards other integrin-expressing cells, correlated with integrin-mediated cell uptake and consequent highly increased levels of apoptotic activity, without perturbing cells not expressing the α5 integrin subunit.
Collapse
Affiliation(s)
- Rossella De Marco
- Department of Agricultural, Food, Enviromental and Animal Sciences (DI4A), University of Udine, 33100 Udine, Italy;
| | - Enrico Rampazzo
- Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy; (E.R.); (J.Z.); (L.P.); (F.G.)
| | - Junwei Zhao
- Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy; (E.R.); (J.Z.); (L.P.); (F.G.)
| | - Luca Prodi
- Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy; (E.R.); (J.Z.); (L.P.); (F.G.)
| | - Mayra Paolillo
- Department of Drugs Sciences, University of Pavia, 27100 Pavia, Italy;
| | - Pierre Picchetti
- Institut de Science et d’Ingénierie Supramoléculaires (ISIS), Université de Strasbourg, 67083 Strasbourg, France;
| | - Francesca Gallo
- Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy; (E.R.); (J.Z.); (L.P.); (F.G.)
| | - Natalia Calonghi
- Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy
| | - Luca Gentilucci
- Department of Chemistry “G. Ciamician”, University of Bologna, 40126 Bologna, Italy; (E.R.); (J.Z.); (L.P.); (F.G.)
| |
Collapse
|
6
|
Raposo Moreira Dias A, Bodero L, Martins A, Arosio D, Gazzola S, Belvisi L, Pignataro L, Steinkühler C, Dal Corso A, Gennari C, Piarulli U. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α V β 3. ChemMedChem 2019; 14:938-942. [PMID: 30840356 PMCID: PMC6593765 DOI: 10.1002/cmdc.201900049] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2019] [Revised: 02/26/2019] [Indexed: 11/09/2022]
Abstract
This work reports the synthesis of a series of small-molecule-drug conjugates containing the αV β3 -integrin ligand cyclo[DKP-RGD] or cyclo[DKP-isoDGR], a lysosomally cleavable Val-Ala (VA) linker or an "uncleavable" version devoid of this sequence, and monomethyl auristatin E (MMAE) or F (MMAF) as the cytotoxic agent. The conjugates were obtained via a straightforward synthetic scheme taking advantage of a copper-catalyzed azide-alkyne cycloaddition as the key step. The conjugates were tested for their binding affinity for the isolated αv β3 receptor and were shown to retain nanomolar IC50 values, in the same range as those of the free ligands. The cytotoxic activity of the conjugates was evaluated in cell viability assays with αv β3 integrin overexpressing human glioblastoma (U87) and human melanoma (M21) cells. The conjugates possess markedly lower cytotoxic activity than the free drugs, which is consistent with inefficient integrin-mediated internalization. In almost all cases the conjugates featuring isoDGR as integrin ligand exhibited higher potency than their RGD counterparts. In particular, the cyclo[DKP-isoDGR]-VA-MMAE conjugate has low nanomolar IC50 values in cell viability assays with both cancer cell lines tested (U87: 11.50±0.13 nm; M21: 6.94±0.09 nm) and is therefore a promising candidate for in vivo experiments.
Collapse
Affiliation(s)
| | - Lizeth Bodero
- Università degli Studi dell'InsubriaDipartimento di Scienza e Alta TecnologiaVia Valleggio, 1122100ComoItaly
| | - Ana Martins
- Exiris SrlVia di Castel Romano, 10000128RomeItaly
| | - Daniela Arosio
- CNRIstituto di Scienze e Tecnologie Molecolari (ISTM)Via C. Golgi, 1920133MilanItaly
| | - Silvia Gazzola
- Università degli Studi dell'InsubriaDipartimento di Scienza e Alta TecnologiaVia Valleggio, 1122100ComoItaly
| | - Laura Belvisi
- Università degli Studi di MilanoDipartimento di ChimicaVia C. Golgi, 1920133MilanItaly
- CNRIstituto di Scienze e Tecnologie Molecolari (ISTM)Via C. Golgi, 1920133MilanItaly
| | - Luca Pignataro
- Università degli Studi di MilanoDipartimento di ChimicaVia C. Golgi, 1920133MilanItaly
| | | | - Alberto Dal Corso
- Università degli Studi di MilanoDipartimento di ChimicaVia C. Golgi, 1920133MilanItaly
| | - Cesare Gennari
- Università degli Studi di MilanoDipartimento di ChimicaVia C. Golgi, 1920133MilanItaly
- CNRIstituto di Scienze e Tecnologie Molecolari (ISTM)Via C. Golgi, 1920133MilanItaly
| | - Umberto Piarulli
- Università degli Studi dell'InsubriaDipartimento di Scienza e Alta TecnologiaVia Valleggio, 1122100ComoItaly
| |
Collapse
|
7
|
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment. Comput Struct Biotechnol J 2019; 17:142-150. [PMID: 30766663 PMCID: PMC6360406 DOI: 10.1016/j.csbj.2019.01.009] [Citation(s) in RCA: 61] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2018] [Revised: 01/16/2019] [Accepted: 01/19/2019] [Indexed: 01/07/2023] Open
Abstract
Inhibitor of apoptosis (IAP) proteins are characterized by the presence of the conserved baculoviral IAP repeat (BIR) domain that is involved in protein-protein interactions. IAPs were initially thought to be mainly responsible for caspase inhibition, acting as negative regulators of apoptosis, but later works have shown that IAPs also control a plethora of other different cellular pathways. As X-linked IAP (XIAP), and other IAP, levels are often deregulated in cancer cells and have been shown to correlate with patients' prognosis, several approaches have been pursued to inhibit their activity in order to restore apoptosis. Many small molecules have been designed to target the BIR domains, the vast majority being inspired by the N-terminal tetrapeptide of Second Mitochondria-derived Activator of Caspases/Direct IAp Binding with Low pI (Smac/Diablo), which is the natural XIAP antagonist. These compounds are therefore usually referred to as Smac mimetics (SMs). Despite the fact that SMs were intended to specifically target XIAP, it has been shown that they also interact with cellular IAP-1 (cIAP1) and cIAP2, promoting their proteasome-dependent degradation. SMs have been tested in combination with several cytotoxic compounds and are now considered promising immune modulators which can be exploited in cancer therapy, especially in combination with immune checkpoint inhibitors. In this review, we give an overview of the structural hot-spots of BIRs, focusing on their fold and on the peculiar structural patches which characterize the diverse BIRs. These structures are exploited/exploitable for the development of specific and active IAP inhibitors.
Collapse
|
8
|
Abstract
There is a growing interest for the discovery of new cancer-targeted delivery systems for drug delivery and diagnosis. A synopsis of the bibliographic data will be presented on bombesin, neurotensin, octreotide, Arg-Gly-Asp, luteinizing hormone-releasing hormone and other peptides. Many of them have reached the clinics for therapeutic or diagnostic purposes, and have been utilized as carriers of known cytotoxic agents such as doxorubicin, paclitaxel, cisplatin, methotrexate or dyes and radioisotopes. In our article, recent advances in the development of peptides as carriers of cytotoxic drugs or radiometals will be analyzed.
Collapse
|
9
|
López Rivas P, Ranđelović I, Raposo Moreira Dias A, Pina A, Arosio D, Tóvári J, Mező G, Dal Corso A, Pignataro L, Gennari C. Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and αV
β3
-Integrin Ligands for Tumor Targeting. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800447] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Paula López Rivas
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi, 19 20133 Milan Italy
| | - Ivan Ranđelović
- Department of Experimental Pharmacology; National Institute of Oncology; Ráth György u. 7-9. 1122 Budapest Hungary
| | | | - Arianna Pina
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi, 19 20133 Milan Italy
| | - Daniela Arosio
- CNR; Istituto di Scienze e Tecnologie Molecolari (ISTM); Via C. Golgi, 19 20133 Milan Italy
| | - József Tóvári
- Department of Experimental Pharmacology; National Institute of Oncology; Ráth György u. 7-9. 1122 Budapest Hungary
| | - Gábor Mező
- Faculty of Science; Institute of Chemistry; Eötvös Loránd University; Pázmány Péter st. 1/A 1117 Budapest Hungary
| | - Alberto Dal Corso
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi, 19 20133 Milan Italy
| | - Luca Pignataro
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi, 19 20133 Milan Italy
| | - Cesare Gennari
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi, 19 20133 Milan Italy
- CNR; Istituto di Scienze e Tecnologie Molecolari (ISTM); Via C. Golgi, 19 20133 Milan Italy
| |
Collapse
|
10
|
Raposo Moreira Dias A, Pina A, Dal Corso A, Arosio D, Belvisi L, Pignataro L, Caruso M, Gennari C. Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α V β 3. Chemistry 2017; 23:14410-14415. [PMID: 28816404 PMCID: PMC5656903 DOI: 10.1002/chem.201703093] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Indexed: 11/29/2022]
Abstract
This work reports the synthesis of three multimeric RGD peptidomimetic‐paclitaxel conjugates featuring a number of αVβ3 integrin ligands ranging from 2 to 4. These constructs were assembled by conjugation of the integrin αVβ3 ligand cyclo[DKP‐RGD]‐CH2NH2 with paclitaxel via a 2′‐carbamate with a self‐immolative spacer, the lysosomally cleavable Val‐Ala dipeptide linker, a multimeric scaffold, a triazole linkage, and finally a PEG spacer. Two monomeric conjugates were also synthesized as reference compounds. Remarkably, the new multimeric conjugates showed a binding affinity for the purified integrin αVβ3 receptor that increased with the number of integrin ligands (reaching a minimum IC50 value of 1.2 nm for the trimeric), thus demonstrating that multivalency is an effective strategy to strengthen the ligand–target interactions.
Collapse
Affiliation(s)
- André Raposo Moreira Dias
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072
| | - Arianna Pina
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072
| | - Alberto Dal Corso
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072
| | - Daniela Arosio
- CNR, Istituto di Scienze e Tecnologie Molecolari (ISTM), Via C. Golgi, 19, 20133, Milan, Italy
| | - Laura Belvisi
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072.,CNR, Istituto di Scienze e Tecnologie Molecolari (ISTM), Via C. Golgi, 19, 20133, Milan, Italy
| | - Luca Pignataro
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072
| | - Michele Caruso
- Nerviano Medical Sciences, Viale Pasteur, 10, 20014, Nerviano, Italy
| | - Cesare Gennari
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy), Fax: (+39) 02-5031-4072.,CNR, Istituto di Scienze e Tecnologie Molecolari (ISTM), Via C. Golgi, 19, 20133, Milan, Italy
| |
Collapse
|
11
|
Pina A, Dal Corso A, Caruso M, Belvisi L, Arosio D, Zanella S, Gasparri F, Albanese C, Cucchi U, Fraietta I, Marsiglio A, Pignataro L, Donati D, Gennari C. Targeting Integrin αV
β3
with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario. ChemistrySelect 2017. [DOI: 10.1002/slct.201701052] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Arianna Pina
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| | - A. Dal Corso
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| | - Michele Caruso
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Laura Belvisi
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| | - Daniela Arosio
- Istituto di Scienze e Tecnologie Molecolari (ISTM); CNR; Via C. Golgi 19 20133 Milano Italy
| | - Simone Zanella
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| | - Fabio Gasparri
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Clara Albanese
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Ulisse Cucchi
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Ivan Fraietta
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Aurelio Marsiglio
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Luca Pignataro
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| | - Daniele Donati
- Nerviano Medical Sciences (NMS); Via Pasteur 10 20014 Nerviano Italy
| | - Cesare Gennari
- Dipartimento di Chimica; Università degli Studi di Milano; Via C. Golgi 19 20133 Milano Italy
| |
Collapse
|
12
|
Zanella S, Angerani S, Pina A, López Rivas P, Giannini C, Panzeri S, Arosio D, Caruso M, Gasparri F, Fraietta I, Albanese C, Marsiglio A, Pignataro L, Belvisi L, Piarulli U, Gennari C. Tumor Targeting with an isoDGR-Drug Conjugate. Chemistry 2017; 23:7910-7914. [PMID: 28449309 PMCID: PMC5488297 DOI: 10.1002/chem.201701844] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Indexed: 11/20/2022]
Abstract
Herein we report the first example of an isoDGR-drug conjugate (2), designed to release paclitaxel selectively within cancer cells expressing integrin αV β3 . Conjugate 2 was synthesized by connecting the isoDGR peptidomimetic 5 with paclitaxel via the lysosomally cleavable Val-Ala dipeptide linker. Conjugate 2 displayed a low nanomolar affinity for the purified integrin αV β3 receptor (IC50 =11.0 nm). The tumor targeting ability of conjugate 2 was assessed in vitro in anti-proliferative assays on two isogenic cancer cell lines characterized by different integrin αV β3 expression: human glioblastoma U87 (αV β3 +) and U87 β3 -KO (αV β3 -). The isoDGR-PTX conjugate 2 displayed a remarkable targeting index (TI=9.9), especially when compared to the strictly related RGD-PTX conjugate 4 (TI=2.4).
Collapse
Affiliation(s)
- Simone Zanella
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Simona Angerani
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Arianna Pina
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Paula López Rivas
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Clelia Giannini
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Silvia Panzeri
- Dipartimento di Scienza e Alta TecnologiaUniversità degli Studi dell'InsubriaVia Valleggio 1122100ComoItaly
| | - Daniela Arosio
- Istituto di Scienze e Tecnologie Molecolari (ISTM)CNRVia C. Golgi 1920133MilanoItaly
| | - Michele Caruso
- Nerviano Medical Sciences (NMS)Via Pasteur 1020014NervianoItaly
| | - Fabio Gasparri
- Nerviano Medical Sciences (NMS)Via Pasteur 1020014NervianoItaly
| | - Ivan Fraietta
- Nerviano Medical Sciences (NMS)Via Pasteur 1020014NervianoItaly
| | - Clara Albanese
- Nerviano Medical Sciences (NMS)Via Pasteur 1020014NervianoItaly
| | | | - Luca Pignataro
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Laura Belvisi
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| | - Umberto Piarulli
- Dipartimento di Scienza e Alta TecnologiaUniversità degli Studi dell'InsubriaVia Valleggio 1122100ComoItaly
| | - Cesare Gennari
- Dipartimento di ChimicaUniversità degli Studi di MilanoVia C. Golgi 1920133MilanoItaly
| |
Collapse
|
13
|
Abstract
Conjugates of cytotoxic agents with RGD peptides (Arg-Gly-Asp) addressed to ανβ3, α5β1 and ανβ6 integrin receptors overexpressed by cancer cells, have recently gained attention as potential selective anticancer chemotherapeutics. In this review, the design and the development of RGD conjugates coupled to different small molecules including known cytotoxic drugs and natural products will be discussed.
Collapse
|
14
|
Berthet M, Martinez J, Parrot I. MgI
2
‐chemoselective cleavage for removal of amino acid protecting groups: A fresh vision for peptide synthesis. Pept Sci (Hoboken) 2017; 108. [DOI: 10.1002/bip.22908] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2016] [Revised: 06/28/2016] [Accepted: 07/04/2016] [Indexed: 12/21/2022]
Affiliation(s)
- Mathéo Berthet
- Institut des Biomolécules Max Mousseron, IBMM UMR‐5247 CNRS, Université de Montpellier, ENSCMCC17‐03, Pl. E. Bataillon, 34095 Montpellier Cedex 5 France
| | - Jean Martinez
- Institut des Biomolécules Max Mousseron, IBMM UMR‐5247 CNRS, Université de Montpellier, ENSCMCC17‐03, Pl. E. Bataillon, 34095 Montpellier Cedex 5 France
| | - Isabelle Parrot
- Institut des Biomolécules Max Mousseron, IBMM UMR‐5247 CNRS, Université de Montpellier, ENSCMCC17‐03, Pl. E. Bataillon, 34095 Montpellier Cedex 5 France
| |
Collapse
|
15
|
Pilkington-Miksa M, Araldi EMV, Arosio D, Belvisi L, Civera M, Manzoni L. New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics. Org Biomol Chem 2016; 14:3221-33. [PMID: 26917057 DOI: 10.1039/c6ob00287k] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
We have designed a new synthetic strategy for the preparation of a new class of cyclic RGD integrin ligands in which the azabicycloalkane scaffold can be envisaged as a (γ,α) dipeptide mimic. The synthesis and in vitro biological evaluation of these RGD derivatives, as well as the computational study of their conformational properties and binding modes to αVβ3 integrin are described. Compound has shown to be a promising candidate as αVβ3 integrin antagonist able to interfere with both cell adhesion and movement on vitronectin with no evidence of cytotoxic effects.
Collapse
Affiliation(s)
- M Pilkington-Miksa
- Centro Interdisciplinare Studi Biomolecolari e Applicazioni Industriali, Università degli Studi di Milano, Via Fantoli 16/15, I-20138, Milano
| | - E M V Araldi
- Centro Interdisciplinare Studi Biomolecolari e Applicazioni Industriali, Università degli Studi di Milano, Via Fantoli 16/15, I-20138, Milano
| | - D Arosio
- Istituto di Scienze e Tecnologie Molecolari, Consiglio Nazionale delle Ricerche, Via C. Golgi 19, I-20133, Milano.
| | - L Belvisi
- Dipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi 19, I-20133, Milano
| | - M Civera
- Dipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi 19, I-20133, Milano
| | - L Manzoni
- Istituto di Scienze e Tecnologie Molecolari, Consiglio Nazionale delle Ricerche, Via C. Golgi 19, I-20133, Milano.
| |
Collapse
|
16
|
Manzoni L, Gornati D, Manzotti M, Cairati S, Bossi A, Arosio D, Lecis D, Seneci P. Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents. Bioorg Med Chem Lett 2016; 26:4613-4619. [PMID: 27578248 DOI: 10.1016/j.bmcl.2016.08.065] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2016] [Revised: 08/18/2016] [Accepted: 08/20/2016] [Indexed: 10/21/2022]
Abstract
Dual action compounds (DACs) based on 4-substituted aza-bicyclo[5.3.0]decane Smac mimetic scaffolds (ABDs) linked to a Zn(2+)-chelating moiety (DPA, o-hydroxy, m-allyl, N-acyl (E)-phenylhydrazone) through their 10 position are reported and characterized. Their synthesis, their target affinity (XIAP BIR3, Zn(2+)) in cell-free assays, their pro-apoptotic effects and cytotoxicity in tumor cells with varying sensitivity to Smac mimetics are described. The results are interpreted to evaluate the influence of Zn(2+) chelators on cell-free potency and on cellular permeability of DACs, and to propose novel avenues towards more potent antitumoral DACs based on Smac mimetics and Zn(2+) chelation.
Collapse
Affiliation(s)
- Leonardo Manzoni
- Istituto di Scienze e Tecnologie Molecolari (ISTM), Consiglio Nazionale delle Ricerche (CNR), Via Golgi 19, I-20133 Milan, Italy
| | - Davide Gornati
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, I-20133 Milan, Italy
| | - Mattia Manzotti
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, I-20133 Milan, Italy
| | - Silvia Cairati
- Istituto di Scienze e Tecnologie Molecolari (ISTM), Consiglio Nazionale delle Ricerche (CNR), Via Golgi 19, I-20133 Milan, Italy
| | - Alberto Bossi
- Istituto di Scienze e Tecnologie Molecolari (ISTM), Consiglio Nazionale delle Ricerche (CNR), Via Golgi 19, I-20133 Milan, Italy; SmartMatLab, Centre, Via Golgi 19, I-20133 Milan, Italy
| | - Daniela Arosio
- Istituto di Scienze e Tecnologie Molecolari (ISTM), Consiglio Nazionale delle Ricerche (CNR), Via Golgi 19, I-20133 Milan, Italy; SmartMatLab, Centre, Via Golgi 19, I-20133 Milan, Italy
| | - Daniele Lecis
- Dipartimento di Oncologia Sperimentale e Medicina Molecolare, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, I-20133 Milan, Italy
| | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, I-20133 Milan, Italy.
| |
Collapse
|
17
|
Zanella S, Mingozzi M, Dal Corso A, Fanelli R, Arosio D, Cosentino M, Schembri L, Marino F, De Zotti M, Formaggio F, Pignataro L, Belvisi L, Piarulli U, Gennari C. Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors. ChemistryOpen 2015; 4:633-41. [PMID: 26491644 PMCID: PMC4608532 DOI: 10.1002/open.201500062] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2015] [Indexed: 12/17/2022] Open
Abstract
A dual-action ligand targeting both integrin αVβ3 and vascular endothelial growth factor receptors (VEGFRs), was synthesized via conjugation of a cyclic peptidomimetic αVβ3 Arg-Gly-Asp (RGD) ligand with a decapentapeptide. The latter was obtained from a known VEGFR antagonist by acetylation at the Lys13 side chain. Functionalization of the precursor ligands was carried out in solution and in the solid phase, affording two fragments: an alkyne VEGFR ligand and the azide integrin αVβ3 ligand, which were conjugated by click chemistry. Circular dichroism studies confirmed that both the RGD and VEGFR ligand portions of the dual-action compound substantially adopt the biologically active conformation. In vitro binding assays on isolated integrin αVβ3 and VEGFR-1 showed that the dual-action conjugate retains a good level of affinity for both its target receptors, although with one order of magnitude (10/20 times) decrease in potency. The dual-action ligand strongly inhibited the VEGF-induced morphogenesis in Human Umbilical Vein Endothelial Cells (HUVECs). Remarkably, its efficiency in preventing the formation of new blood vessels was similar to that of the original individual ligands, despite the worse affinity towards integrin αVβ3 and VEGFR-1.
Collapse
Affiliation(s)
- Simone Zanella
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| | - Michele Mingozzi
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| | - Alberto Dal Corso
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| | - Roberto Fanelli
- Dipartimento di Scienza e Alta Tecnologia, Università degli Studi dell'InsubriaVia Valleggio 11, 22100, Como, Italy
| | - Daniela Arosio
- Istituto di Scienze e Tecnologie Molecolari (ISTM), National Research Council (CNR)Via C. Golgi 19, 20133, Milan, Italy
| | - Marco Cosentino
- Center for Research in Medical Pharmacology, Università degli Studi dell'InsubriaVia Ottorino Rossi 9, 21100, Varese, Italy
| | - Laura Schembri
- Center for Research in Medical Pharmacology, Università degli Studi dell'InsubriaVia Ottorino Rossi 9, 21100, Varese, Italy
| | - Franca Marino
- Center for Research in Medical Pharmacology, Università degli Studi dell'InsubriaVia Ottorino Rossi 9, 21100, Varese, Italy
| | - Marta De Zotti
- Istituto di Chimica Biomolecolare, CNR, Unità di Padova, Dipartimento di Chimica, Università degli Studi di PadovaVia Marzolo 1, 35131, Padova, Italy
| | - Fernando Formaggio
- Istituto di Chimica Biomolecolare, CNR, Unità di Padova, Dipartimento di Chimica, Università degli Studi di PadovaVia Marzolo 1, 35131, Padova, Italy
| | - Luca Pignataro
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| | - Laura Belvisi
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| | - Umberto Piarulli
- Dipartimento di Scienza e Alta Tecnologia, Università degli Studi dell'InsubriaVia Valleggio 11, 22100, Como, Italy
| | - Cesare Gennari
- Dipartimento di Chimica, Università degli Studi di MilanoVia C. Golgi 19, 20133, Milan, Italy
| |
Collapse
|
18
|
Liu Y, Mei L, Yu Q, Zhang Q, Gao H, Zhang Z, He Q. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides. Amino Acids 2015; 47:2533-9. [DOI: 10.1007/s00726-015-2043-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2015] [Accepted: 07/01/2015] [Indexed: 01/01/2023]
|
19
|
Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Donati D, Gennari C. Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers. Chemistry 2015; 21:6921-9. [DOI: 10.1002/chem.201500158] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2015] [Indexed: 11/06/2022]
|
20
|
Abstract
For nearly two decades now, the RGD (Arg-Gly-Asp)-binding αvβ3-integrin has been a focus of anti-angiogenic drug design. These inhibitors are well-tolerated, but have shown only limited success in patients. Over the years, studies in β3-integrin-knockout mice have shed some light on possible explanations for disappointing clinical outcomes. However, studying angiogenesis in β3-integrin-knockout mice is a blunt tool to investigate β3-integrin's role in pathological angiogenesis. Since establishing our laboratory at University of East Anglia (UEA), we have adopted more refined models of genetically manipulating the expression of the β3-integrin subunit. The present review will highlight some of our findings from these models and describe how data from them have forced us to rethink how targeting αvβ3-integrin expression affects tumour angiogenesis and cancer progression. Revisiting the fundamental biology behind how this integrin regulates tumour growth and angiogenesis, we believe, is the key not only to understanding how angiogenesis is normally co-ordinated, but also in success with drugs directed against it.
Collapse
|